Diagnostics startup Cyted Health secures $44M Series B
Diagnostics startup Cyted Health secures $44M Series B Gastrointestinal diagnostics startup Cyted Health has secured $44 million in Series B funding, led by EQT Life Sciences, with Advent Life Sciences and the British Business Bank (formerly British Patient Capital) joining as co-leads. Existing investors Morningside and BGF also participated in

